Epilepsy with Myoclonic Absences in Adults (Age 16 and Older)

Managing epilepsy with myoclonic absences in adult patients aged 16 and older presents a distinct clinical challenge — particularly when seizures persist despite antiepileptic drug (AED) therapy.

Patient scenario Adult patients (age 16 and older) with epilepsy with myoclonic absences who have continued seizures despite appropriate AED therapy — cases that warrant evaluation for alternative treatment strategies.

Treatment approach (partial overview)

For adults with medically refractory myoclonic absences, non-pharmacologic alternatives may be considered. The full protocol outlines specific interventions and the criteria used to select among them.

Complete regimen, selection criteria, and sequencing available via the link below.

Instant Access to Structured Evidence-Based Regimens

References

Adults

These patients have continued seizures despite appropriate AED therapy.

For patients with seizures that are not controlled with these agents, alternative treatments include surgical resection of the seizure focus, ketogenic diets, vagus nerve stimulators, and implantable brain neurostimulators.

View source ↗